Urine glycosaminoglycan profiles (GAGomes) have high sensitivity for nonmetastatic clear-cell renal cell carcinoma (M0ccRCC) recurrence.
TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...
and clear-cell renal cell carcinoma. (HealthDay News) — Lifetime excess weight and adult weight gain are associated with an increased risk for renal cell carcinoma (RCC), according to a study ...
A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...
4d
Clinical Trials Arena on MSNElypta’s urine test identifies 90% of recurrent kidney cancer casesThe AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery ...
A simple urine test could accurately detect recurring kidney cancer in patients recovering from surgery for the disease, ...
Bio-Techne Corporation today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet needs in ...
A cell therapy is a medicinal product containing cells, and is typically injected into a patient. Examples include bone marrow transplants (also known as haematopoietic stem cell transplantation ...
Advanced Pharmacy Australia [AdPha] (formerly Society of Hospital Pharmacists of Australia), Australian and New Zealand Urogenital and Prostate Cancer Trials Group and The UK Renal Pharmacy Group.
Mar. 26, 2025 — Researchers have developed 'tomoseqr' -- a new software tool that enables easy estimation of the three-dimensional (3D) spatial distribution of gene expression. Tomoseqr is free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results